PROCEPT BioRobotics (PRCT)
(Delayed Data from NSDQ)
$69.19 USD
+3.88 (5.94%)
Updated May 15, 2024 04:00 PM ET
After-Market: $69.17 -0.02 (-0.03%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth B Momentum F VGM
Price, Consensus and EPS Surprise
PRCT 69.19 +3.88(5.94%)
Will PRCT be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for PRCT based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for PRCT
PROCEPT BioRobotics Corporation (PRCT) Reports Q1 Loss, Tops Revenue Estimates
Accelerate Diagnostics (AXDX) Reports Q4 Loss, Misses Revenue Estimates
PRCT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Masimo (MASI) Soars 3.3%: Is Further Upside Left in the Stock?
Is SPDR S&P Health Care Equipment ETF (XHE) a Strong ETF Right Now?
Teleflex (TFX) Q4 Earnings and Revenues Surpass Estimates
Other News for PRCT
What's Driving NovoCure Ltd's Surprising 29% Stock Rally?
From Science Fiction to Reality: 3 Robotics Stocks for Automatic Riches
PROCEPT BioRobotics to Present at Upcoming 2024 Leerink Partners Healthcare Crossroads Conference and 44th Annual William Blair Growth Stock Conference
Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (PRCT), Amgen (AMGN) and Elevation Oncology (ELEV)
Unveiling 4 Analyst Insights On PROCEPT BioRobotics